Patents by Inventor Terumi Nakajima

Terumi Nakajima has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 7560286
    Abstract: A method for effectively causing charge-remote fragmentation (CRF) when the structural analysis of an nitrogen-containing organic compound is performed using a high-energy collisional-induced dissociation-mass/mass spectrum (CID-MS/MS spectrum), a reagent to be used in such a method, and a method for analyzing an organic compound by the induction of CRF are provided. The method for the induction of charge-remote fragmentation (CRF) using a high-energy collisional-induced dissociation-mass/mass spectrum (CID-MS/MS spectrum) has the step of: introducing a squaric acid residue into an end of a nitrogen-containing organic compound. The squaric acid residue is represented by a chemical formula (I): The reagent is provided for introducing such a squaric acid residue. Furthermore, the method is provided for analyzing such an organic compound by the induction of CRF.
    Type: Grant
    Filed: March 12, 2002
    Date of Patent: July 14, 2009
    Assignee: Suntory Holdings Limited
    Inventors: Hideo Naoki, Terumi Nakajima, Yasufumi Ohfune, Tetsuro Shinada, Kazuya Murata
  • Patent number: 7282577
    Abstract: Hemolytic proteins offer new approaches to drug development. The hemolytic proteins are obtained from a nematocyst of Carybdea alata. Alternatively, the proteins may be recovered from cultured cells transfected with the sequence encoding the hemolytic protein of Carybdea alata.
    Type: Grant
    Filed: December 30, 2004
    Date of Patent: October 16, 2007
    Assignee: Suntory Limited
    Inventors: Hiroshi Nagai, Kyoko Kuroda, Terumi Nakajima
  • Patent number: 7250491
    Abstract: Novel proteins providing the new approach to development of the drugs and pesticides with the use or application of a hemolytic activity, and novel proteins having the following properties and the genes encoding thereof are provided: (1) having hemolytic activity; (2) having a molecular weight of about 50,000 Da (determined by SDS gel electrophoresis); (3) having an amino acid sequence represented by any of SEQ ID NO 1 to SEQ ID NO 3 as a partial amino acid sequence; and (4) having an amino acid sequence represented by SEQ ID NO 5 as the full amino acid sequence.
    Type: Grant
    Filed: August 29, 2003
    Date of Patent: July 31, 2007
    Assignee: Suntory Limited
    Inventors: Hiroshi Nagai, Terumi Nakajima
  • Publication number: 20050106676
    Abstract: Hemolytic proteins offer new approaches to drug development. The hemolytic proteins are obtained from a nematocyst of Carybdea alata. Alternatively, the proteins may be recovered from cultured cells transfected with the sequence encoding the hemolytic protein of Carybdea alata.
    Type: Application
    Filed: December 30, 2004
    Publication date: May 19, 2005
    Applicant: SUNTORY LIMITED
    Inventors: Hiroshi Nagai, Kyoko Kuroda, Terumi Nakajima
  • Publication number: 20050074864
    Abstract: Novel proteins providing the new approach to development of the drugs and pesticides with the use or application of a hemolytic activity, and novel proteins having the following properties and the genes encoding thereof are provided: (1) having hemolytic activity; (2) having a molecular weight of about 50,000 Da (determined by SDS gel electrophoresis); (3) having an amino acid sequence represented by any of SEQ ID NO 1 to SEQ ID NO 3 as a partial amino acid sequence; and (4) having an amino acid sequence represented by SEQ ID NO 5 as the full amino acid sequence.
    Type: Application
    Filed: August 29, 2003
    Publication date: April 7, 2005
    Applicant: Suntory Limited
    Inventors: Hiroshi Nagai, Terumi Nakajima
  • Patent number: 6855803
    Abstract: Novel proteins having hemolytic activity giving the new approach of development of the drugs, and having the following property are provided: (1) having hemolytic activity; (2) having a molecular weight of about 50,000 Da (determined by SDS gel electrophoresis); and (3) having an amino acid sequence represented by any of SEQ ID NO 1 and SEQ ID NO 2 as a partial amino acid sequence represented by the following amino acid sequences (1) and (2); Amino acid sequence (1): Tyr-Arg-Asp-Gln-Glu-Leu-Glu-Asp-Asn-Val-Lys Amino acid sequence (2): Lys-Trp-Pro-Asp-Tyr-Phe-Val-Tyr-Met-Glu-Ser-Ser-Ala-His-Gly-Tyr-Ile-Arg (wherein, an amino acid residue is written by the 3 letters notation defined by IUPAC and IUB) obtained from nematocyst of Carybdea alata.
    Type: Grant
    Filed: March 21, 2001
    Date of Patent: February 15, 2005
    Assignee: Suntory Limited
    Inventors: Hiroshi Nagai, Terumi Nakajima, Kyoko Kuroda
  • Publication number: 20040235062
    Abstract: A method is disclosed for identifying or analyzing, easily and in a short time, the molecular weight, the chemical species of molecules, and the structure of molecules, of a protein present on the superficial layer of cells or in cells, or a substance interacting with the protein. This method comprises the steps of: bringing the cells having the protein and the substance interacting with the protein into contact with each other to cause the substance to interact with the cells; purifying the cells, with the cells and the substance in an interacting state; irradiating the purified cells with a laser to ionize the substance directly; and analyzing the ionized substance by mass spectrometry.
    Type: Application
    Filed: June 22, 2004
    Publication date: November 25, 2004
    Inventors: Terumi Nakajima, Hideo Naoki, Akikazu Yasuda, Keiko Iwasa
  • Publication number: 20040137420
    Abstract: An improved method for directly identifying a chemical structure of a substance present in tissue or cells of organisms is disclosed.
    Type: Application
    Filed: December 13, 2002
    Publication date: July 15, 2004
    Inventors: Akikazu Yasuda, Yoshimi Yasuda, Terumi Nakajima
  • Publication number: 20040110919
    Abstract: Novel proteins having hemolytic activity giving the new approach of development of the drugs, and having the following property are provided:
    Type: Application
    Filed: November 21, 2001
    Publication date: June 10, 2004
    Inventors: Hiroshi Nagai, Terumi Nakajima
  • Publication number: 20040067525
    Abstract: A method for effectively causing charge-remote fragmentation (CRF) when the structural analysis of an nitrogen-containing organic compound is performed using a high-energy collisional-induced dissociation-mass/mass spectrum (CID-MS/MS spectrum), a reagent to be used in such a method, and a method for analyzing an organic compound by the induction of CRF are provided. The method for the induction of charge-remote fragmentation (CRF) using a high-energy collisional-induced dissociation-mass/mass spectrum (CID-MS/MS spectrum) has the step of: introducing a squaric acid residue into an end of a nitrogen-containing organic compound.
    Type: Application
    Filed: March 12, 2002
    Publication date: April 8, 2004
    Applicant: Suntory Limited
    Inventors: Hideo Naoki, Terumi Nakajima, Yasufumi Ohfune, Tetsuro Shinada, Kazuya Murata
  • Patent number: 6689749
    Abstract: The invention provides a peptide capable of blocking voltage-gated K+ channels and inhibiting IL-2 production, which is represented by an amino acid sequence of: Ala-Ser-Cys-Arg-Thr-Pro-Lys-Asp-Cys-Ala-Asp-Pro-Cys-Arg-Lys-Glu-Thr-Gly-Cys-Pro-Tyr-Gly-Lys-Cys-Met-Asn-Arg-Lys-Cys-Lys-Cys-Asn-Arg-Cys; in which the C-terminal is amidated and four disulfide bridges are present in the molecule, and their related peptides isolated from the venom gland of a scorpion Heterometrus spinnifer. The peptides provided by the present invention are neuropeptides which can block voltage-gated K+ channels and inhibit IL-2 production at an extremely low concentration and, therefore, are expected to contribute to application of scorpion toxins to medicines and so on.
    Type: Grant
    Filed: August 26, 1998
    Date of Patent: February 10, 2004
    Assignee: Suntory Limited
    Inventors: Bruno Lebrun, RĂ©gine Romi-Lebrun, Hiroyuki Minakata, Terumi Nakajima, Junko Hashino
  • Patent number: 6653449
    Abstract: Novel proteins providing the new approach to development of the drugs and pesticides with the use or application of a hemolytic activity, and novel proteins having the following properties and the genes encoding thereof are provided: (1) having hemolytic activity; (2) having a molecular weight of about 50,000 Da (determined by SDS gel electrophoresis); (3) having an amino acid sequence represented by any of SEQ ID NO 1 to SEQ ID NO 3 as a partial amino acid sequence; and (4) having an amino acid sequence represented by SEQ ID NO 5 as the full amino acid sequence.
    Type: Grant
    Filed: December 1, 2000
    Date of Patent: November 25, 2003
    Assignee: Suntory Limited
    Inventors: Hiroshi Nagai, Terumi Nakajima
  • Patent number: 5246968
    Abstract: A compound having glutamate receptor inhibitor activity represented by the formula: ##STR1## where R represents a hydrogen atom or a group of the formula: ##STR2## m and n each represents an integer of 3 or 4 and p represents an integer of 0 or 1, or a salt thereof is provided. The compounds are useful for an insecticide.
    Type: Grant
    Filed: June 30, 1992
    Date of Patent: September 21, 1993
    Assignees: Takeda Chimical Industries, Ltd., Tokyo Metropolitan Institute for Neurosciences
    Inventors: Terumi Nakajima, Yoshio Aramaki, Tadashi Yasuhara, Tsutomu Higashijima, Nobufumi Kawai, Akiko Miwa, Masanori Yoshioka
  • Patent number: 5047430
    Abstract: A compound is provided which has the formula ##STR1## wherein m is an integer of 1 to 3;n is an integer of 1 or 2;p is an integer of 1 or 2;q is an integer of 1 to 6;x is an integer of 2 to 6;Ph is phenyleneor a pharmceutically acceptable salt thereof. Also provided is a method for glutamate receptor inhibition which comprises administering to a mammal in need thereof an effective amount of said compound or a pharmaceutically acceptable salt thereof. Compositions for glutamate receptor inhibition are provided which contain an effective amount of said compound to provide a glutamate receptor inhibition effect, together with at least one pharmaceutically acceptable carrier, dilient or excipient therefor.
    Type: Grant
    Filed: April 25, 1989
    Date of Patent: September 10, 1991
    Assignee: Takeda Chemical Industries, Ltd.
    Inventors: Giichi Goto, Terumi Nakajima
  • Patent number: 4990511
    Abstract: Amide compounds having glutamate receptor-inhibiting activity and having the formula: ##STR1## (wherein R.sub.1 and R.sub.2 each is hydrogen atom, an alkyl group or an acyl group, or ##STR2## is a cyclic amino group, m is an integer of 1 to 3, n is an integer of 0 to 4, x is an integer of 2 to 6 and y is an integer of 0 to 3) or salts thereof, are provided. The compounds are useful as a medicine for therapy or/and prevention of sequelae of cerebral apoplexy in warm-blooded animals.
    Type: Grant
    Filed: August 2, 1989
    Date of Patent: February 5, 1991
    Assignee: Takeda Chemical Industries, Ltd.
    Inventors: Terumi Nakajima, Koichi Shudo, Giichi Goto
  • Patent number: 4990614
    Abstract: A compound of the formula: ##STR1## wherein ##STR2## represents a cyclic amino group, A represents a methylene group or a carbonyl group, m represents an integer of 1 to 3, n represents an integer of 0 to 4 and p represents an integer of 1 to 2, or a salt thereof, which has glutamate receptor inhibiting activity is provided.
    Type: Grant
    Filed: October 5, 1988
    Date of Patent: February 5, 1991
    Assignee: Takeda Chemical Industries, Ltd.
    Inventors: Terumi Nakajima, Koichi Shudo, Giichi Goto
  • Patent number: 4918107
    Abstract: A compound of the formula ##STR1## wherein R' is hydrogen atom or an alkyl group, m is an integer of 1 to 3, p is 1 or 2, x is an integer of 2 to 6, and y is an integer of 1 to 3, or a salt thereof, which has glutamate receptor inhibitor activity, a process for preparing the same and an insecticidal composition containing the same are provided.
    Type: Grant
    Filed: June 6, 1988
    Date of Patent: April 17, 1990
    Assignees: Tsumura & Co., Tokyo Metropolitan Institute for Neurosciences, Takeda Chemical Industries, Ltd.
    Inventors: Terumi Nakajima, Nobufumi Kawai, Koichi Shudo, Tetsuo Shiba